Financhill
Back

PureBase Vs. Kymera Therapeutics Industry Stock Comparison

Buy
65

PUBC
PureBase

Last Price:
0.05
Seasonality Move:
-7.22%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.30
Seasonality Move:
65.72%
Buy
65
PureBase (PUBC) is a Buy

Is PureBase a Buy, Sell or Hold?

  • The current PureBase [PUBC] share price is $0.08. The Score for PUBC is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • PUBC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $46.41. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PUBC Stock Price Chart

What is PureBase's stock price today?

  • The PureBase share price today is $0.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PUBC is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $46.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.

PUBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 65.54 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.04 - 0.06) Buy
Bollinger Bands (100): (0.04 - 0.06) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 51.28 Buy
Chaikin Money Flow: 22833 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.9 - 49.54) Sell
Bollinger Bands (100): (35.01 - 48.01) Buy

PUBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.05 Buy
20-day SMA: 0.05 Buy
50-day SMA: 0.05 Buy
200-day SMA: 0.06 Buy
8-day EMA: 0.05 Buy
20-day EMA: 0.05 Buy
50-day EMA: 0.05 Buy
200-day EMA: 0.06 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.1 Buy
20-day SMA: 46.53 Sell
50-day SMA: 46.23 Buy
200-day SMA: 38.73 Buy
8-day EMA: 45.83 Buy
20-day EMA: 45.9 Buy
50-day EMA: 45.24 Buy
200-day EMA: 38.58 Buy

PureBase Earnings Growth & PUBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

PureBase Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):